However, the time × genotype × ACE inhibitor treatment interaction did not reach statistical significance, indicating that exercise capacity trainability in patients treated with ACE inhibitors does not appear to be affected by their ACE genotype (data not shown).
← all excerpts
The angiotensin-converting enzyme I/D polymorphism does not impact training-induced adaptations in exercise capacity in patients with stable coronary artery disease.
1
—
—